News

2016

image004

Jami L. Obermayer, Ph.D.

COG is pleased to announce that Dr. Jami Obermayer has received a contract award from the National Institutes of Health – National Institute on Drug Abuse entitled “Screening Assessment and Resources.” This study is a Phase II, Small Business Innovation Research (SBIR) award that seeks to further develop the Screening and Assessment Resources Phase I product, a comprehensive system designed to facilitate the automated delivery of substance use risk screening, assessment, and referral services. The system will be evaluated in a randomized controlled trial to compare outcomes between the intervention group patients and patients receiving usual customary care.

 

image002

Shannon Gwin Mitchell, Ph.D.

COG is pleased to announce that Dr. Shannon Mitchell, along with Co-Investigators Drs. Steven Carswell and Jami Obermayer, has received a grant award from the National Institutes of Health – National Institute on Alcohol Abuse and Alcoholism (NIAAA) entitled “Computerizing NIAAA’s Best Practices for Youth Screening and Brief Intervention.” This study is a Phase I, Small Business Technology Transfer award that seeks to translate key elements in the NIAAA’s Practitioner’s Guide for pediatric alcohol misuse to a computerized web- and mobile-compatible format. A computerized version of this Guide could dramatically enhance its practical utility for clinicians, thereby increasing the number of youth who receive high-quality alcohol screening and appropriate intervention.

2015

image003

Michael S. Gordon, D.P.A.

COG is pleased to announce that Dr. Michael Gordon, along with Co-Investigators Drs. Steven Carswell and Jami Obermayer, has received a grant award from the National Institutes of Health – National Institute on Minority Health and Health Disparities entitled “Avatar Assisted Therapy for Probationers and Parolees with Substance Use Disorders.” This study is a Phase I, Small Business Technology Transfer award that seeks to develop an Avatar Assisted Therapy (AAT) platform for probationers/parolees with substance use disorders who are in need of outpatient substance abuse treatment. AAT uses the Internet to enable clinicians and clients in substance abuse treatment programs to interact in group sessions from separate and remote locations in real-time through the use of avatars (i.e., digital self-representations).

image003

Michael S. Gordon, D.P.A.

COG is pleased to announce that Dr. Michael Gordon, along with Co-Investigators Drs. Steven Carswell and Jami Obermayer, has received a grant award from the National Institutes of Health – National Institute on Minority Health and Health Disparities entitled “Continuing Care App for Probationers and Parolees with Substance Use Disorders.” This study is a Phase I, Small Business Technology Transfer award that seeks to develop a continuing care mobile application for probationers and parolees completing outpatient substance abuse treatment who are at high risk of substance abuse relapse, HIV related risk factors, and re-arrest and re-incarceration.

image004

Jami L. Obermayer, Ph.D.

COG is pleased to announce that Dr. Jami Obermayer has received a grant award from the National Institutes of Health – National Cancer Institute entitled “Mobile Mindfulness Based Smoking Cessation.” This study is a Phase I, Small Business Innovation Research award that seeks to develop a mindfulness-based smoking cessation program delivered to smokers on their smartphone devices (Android/iPhone). This program is based on the Mindfulness-Based Stress Reduction program tailored for smoking cessation.

2014

image004

Jami L. Obermayer, Ph.D.

COG is pleased to announce that Dr. Jami Obermayer has received a contract award from the National Institutes of Health – National Institute on Drug Abuse entitled “Screening Assessment and Resources.” This study is a Phase I, Small Business Innovation Research award that seeks to design, develop, and evaluate a substance use and related risk behaviors screening and assessment system for providers and patients in healthcare service settings. This system included web-based delivery of substance use risk assessments to patients and web-based delivery of the collected assessment data reports for providers based on this data.

image005

Steven B. Carswell, Ph.D.

COG is pleased to announce that Drs. Steven Carswell, along with Co-Investigators Drs. Michael Gordon and Jami Obermayer, has received a grant award from the National Institutes of Health – National Institute on Drug Abuse entitled “A Daily Client Check-In System for Outpatient Substance Abuse Treatment.” This study is a Phase I, Small Business Technology Transfer award that seeks to develop a phone-based interactive voice response system designed to obtain client report information between weekly substance abuse treatment sessions regarding mood, cravings, substance use, and involvement in recovery support activities. The system was designed to generate a brief, one-page weekly summary report to assist clinicians in assessing client needs and tailoring treatment services.

2013

image006

Cathy J. Reback, Ph.D.

COG is pleased to announce that Dr. Cathy Reback, along with Co-Investigators Drs. Jan Gryczynski and Steven Carswell, and Statistician/Project Director Dr. Jesse Fletcher, has received a grant award from the National Institutes of Health – National Institute on Drug Abuse entitled “Mobile App Targeting Meth Use, HIV Sex Risks, & ART Adherence for Gay/Bisexual Men.” This study is a Phase I, Small Business Technology Transfer award that seeks to conduct formative work to assist in the development of a culturally competent and consumer responsive computerized app for gay/bisexual methamphetamine-using men. The app is designed to reduce methamphetamine use and HIV sexual risk behaviors and to increase antiretroviral therapy (ART) medication adherence.

image004

Jami L. Obermayer, Ph.D.

COG is pleased to announce that Dr. Jami Obermayer has received a contract award from the National Institutes of Health – National Institute on Drug Abuse entitled “MedCheck – Medication Adherence System.” This study is a Phase I, Small Business Technology Transfer award that seeks to develop and evaluate a comprehensive and interactive medication adherence support system for patients and their providers. This system included a web- and mobile-based support system that integrated content delivery and real-time data collection to motivate patients to adhere to their medication treatment plans. Moreover, the system was designed to facilitate ongoing monitoring and communication between patients and providers in-between office visits.